| Year |
Citation |
Score |
| 2019 |
Beauchamp D, Bergeron MG. Pharmacologic Basis for the Treatment of Pyelonephritis. Current Infectious Disease Reports. 1: 371-378. PMID 11095811 DOI: 10.1007/S11908-999-0044-0 |
0.344 |
|
| 2017 |
Maheux AF, Bouchard S, Bérubé È, Bergeron MG. Comparison of MI, Chromocult(®) coliform, and Compass CC chromogenic culture-based methods to detect Escherichia coli and total coliforms in water using 16S rRNA sequencing for colony identification. Journal of Water and Health. 15: 353-359. PMID 28598339 DOI: 10.2166/Wh.2017.174 |
0.302 |
|
| 2017 |
Maheux AF, Bouchard S, Bérubé È, Bergeron MG. Rapid molecular identification of fecal origin-colonies growing on Enterococcus spp.-specific culture methods. Journal of Water and Health. 15: 239-250. PMID 28362305 DOI: 10.2166/Wh.2016.199 |
0.344 |
|
| 2016 |
Lay CL, Dridi L, Bergeron MG, Ouellette M, Fliss IL. Nisin is an effective inhibitor of Clostridium difficile vegetative cells and spore germination. Journal of Medical Microbiology. 65: 169-75. PMID 26555543 DOI: 10.1099/Jmm.0.000202 |
0.305 |
|
| 2015 |
Raymond F, Ouameur AA, Déraspe M, Iqbal N, Gingras H, Dridi B, Leprohon P, Plante PL, Giroux R, Bérubé È, Frenette J, Boudreau DK, Simard JL, Chabot I, Domingo MC, ... ... Bergeron MG, et al. The initial state of the human gut microbiome determines its reshaping by antibiotics. The Isme Journal. PMID 26359913 DOI: 10.1038/Ismej.2015.148 |
0.313 |
|
| 2015 |
Daher RK, Stewart G, Boissinot M, Boudreau DK, Bergeron MG. Influence of sequence mismatches on the specificity of recombinase polymerase amplification technology. Molecular and Cellular Probes. 29: 116-21. PMID 25481659 DOI: 10.1016/J.Mcp.2014.11.005 |
0.32 |
|
| 2014 |
Maheux AF, Boudreau DK, Bisson MA, Dion-Dupont V, Bouchard S, Nkuranga M, Bergeron MG, Rodriguez MJ. Molecular method for detection of total coliforms in drinking water samples. Applied and Environmental Microbiology. 80: 4074-84. PMID 24771030 DOI: 10.1128/Aem.00546-14 |
0.329 |
|
| 2014 |
Daher RK, Stewart G, Boissinot M, Bergeron MG. Isothermal recombinase polymerase amplification assay applied to the detection of group B streptococci in vaginal/anal samples. Clinical Chemistry. 60: 660-6. PMID 24463560 DOI: 10.1373/Clinchem.2013.213504 |
0.344 |
|
| 2014 |
Gravel JF, Geissler M, Chapdelaine S, Boissinot K, Voisin B, Charlebois I, Poirier-Richard HP, Grégoire A, Boissinot M, Bergeron MG, Veres T, Boudreau D. Portable bead-based fluorescence detection system for multiplex nucleic acid testing: A case study with Bacillus anthracis Microfluidics and Nanofluidics. 16: 1075-1087. DOI: 10.1007/S10404-013-1273-Y |
0.303 |
|
| 2013 |
Maheux AF, Bérubé E, Boudreau DK, Villéger R, Cantin P, Boissinot M, Bissonnette L, Bergeron MG. Abilities of the mCP Agar method and CRENAME alpha toxin-specific real-time PCR assay to detect Clostridium perfringens spores in drinking water. Applied and Environmental Microbiology. 79: 7654-61. PMID 24077714 DOI: 10.1128/Aem.02791-13 |
0.309 |
|
| 2013 |
Maheux AF, Bissonnette L, Bergeron MG. Rapid detection of the Escherichia coli genospecies in water by conventional and real-time PCR. Methods in Molecular Biology (Clifton, N.J.). 943: 289-305. PMID 23104298 DOI: 10.1007/978-1-60327-353-4_20 |
0.316 |
|
| 2012 |
Bissonnette L, Bergeron MG. Infectious Disease Management through Point-of-Care Personalized Medicine Molecular Diagnostic Technologies. Journal of Personalized Medicine. 2: 50-70. PMID 25562799 DOI: 10.3390/Jpm2020050 |
0.305 |
|
| 2012 |
Sistek V, Boissinot M, Boudreau DK, Huletsky A, Picard FJ, Bergeron MG. Development of a real-time PCR assay for the specific detection and identification of Streptococcus pseudopneumoniae using the recA gene. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 18: 1089-96. PMID 22022828 DOI: 10.1111/J.1469-0691.2011.03684.X |
0.339 |
|
| 2012 |
Bissonnette L, Bergeron MG. Multiparametric technologies for the diagnosis of syndromic infections Clinical Microbiology Newsletter. 34: 159-168. DOI: 10.1016/J.Clinmicnews.2012.09.003 |
0.329 |
|
| 2011 |
Maheux AF, Bissonnette L, Boissinot M, Bernier JL, Huppé V, Picard FJ, Bérubé É, Bergeron MG. Rapid concentration and molecular enrichment approach for sensitive detection of Escherichia coli and Shigella species in potable water samples. Applied and Environmental Microbiology. 77: 6199-207. PMID 21764965 DOI: 10.1128/Aem.02337-10 |
0.322 |
|
| 2011 |
Maheux AF, Bérubé E, Boudreau DK, Cantin P, Boissinot M, Bissonnette L, Rodrigue L, Bergeron MG. Ability of three DNA-based assays to identify presumptive Escherichia coli colonies isolated from water by the culture-based mFC agar method. Water Research. 45: 2638-46. PMID 21420142 DOI: 10.1016/J.Watres.2011.02.021 |
0.324 |
|
| 2011 |
Maheux AF, Bissonnette L, Boissinot M, Bernier JL, Huppé V, Bérubé E, Boudreau DK, Picard FJ, Huletsky A, Bergeron MG. Method for rapid and sensitive detection of Enterococcus sp. and Enterococcus faecalis/faecium cells in potable water samples. Water Research. 45: 2342-54. PMID 21333318 DOI: 10.1016/J.Watres.2011.01.019 |
0.333 |
|
| 2009 |
Maheux AF, Picard FJ, Boissinot M, Bissonnette L, Paradis S, Bergeron MG. Analytical comparison of nine PCR primer sets designed to detect the presence of Escherichia coli/Shigella in water samples. Water Research. 43: 3019-28. PMID 19482328 DOI: 10.1016/J.Watres.2009.04.017 |
0.307 |
|
| 2009 |
Kukavica-Ibrulj I, Hamelin ME, Prince GA, Gagnon C, Bergeron Y, Bergeron MG, Boivin G. Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia. Journal of Virology. 83: 1341-9. PMID 19019962 DOI: 10.1128/Jvi.01123-08 |
0.484 |
|
| 2008 |
Bergeron MG. Revolutionizing the practice of medicine through rapid (< 1h) DNA-based diagnostics. Clinical and Investigative Medicine. MéDecine Clinique Et Experimentale. 31: E265-71. PMID 18980716 DOI: 10.25011/Cim.V31I5.4873 |
0.333 |
|
| 2007 |
Drummelsmith J, Winstall E, Bergeron MG, Poirier GG, Ouellette M. Comparative proteomics analyses reveal a potential biomarker for the detection of vancomycin-intermediate Staphylococcus aureus strains. Journal of Proteome Research. 6: 4690-702. PMID 17997515 DOI: 10.1021/Pr070521M |
0.34 |
|
| 2007 |
Gauthier JF, Fortin A, Bergeron Y, Dumas MC, Champagne ME, Bergeron MG. Differential contribution of bacterial N-formyl-methionyl-leucyl- phenylalanine and host-derived CXC chemokines to neutrophil infiltration into pulmonary alveoli during murine pneumococcal pneumonia. Infection and Immunity. 75: 5361-7. PMID 17709413 DOI: 10.1128/Iai.02008-06 |
0.499 |
|
| 2007 |
Parham NJ, Picard FJ, Peytavi R, Gagnon M, Seyrig G, Gagné PA, Boissinot M, Bergeron MG. Specific magnetic bead based capture of genomic DNA from clinical samples: application to the detection of group B streptococci in vaginal/anal swabs. Clinical Chemistry. 53: 1570-6. PMID 17660271 DOI: 10.1373/Clinchem.2007.091389 |
0.321 |
|
| 2005 |
Huletsky A, Lebel P, Picard FJ, Bernier M, Gagnon M, Boucher N, Bergeron MG. Identification of methicillin-resistant Staphylococcus aureus carriage in less than 1 hour during a hospital surveillance program. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: 976-81. PMID 15824989 DOI: 10.1086/428579 |
0.346 |
|
| 2005 |
Wang E, Bergeron Y, Bergeron MG. Ceftriaxone pharmacokinetics in interleukin-10-treated murine pneumococcal pneumonia. The Journal of Antimicrobial Chemotherapy. 55: 721-6. PMID 15772139 DOI: 10.1093/Jac/Dki085 |
0.658 |
|
| 2004 |
Picard FJ, Ke D, Boudreau DK, Boissinot M, Huletsky A, Richard D, Ouellette M, Roy PH, Bergeron MG. Use of tuf sequences for genus-specific PCR detection and phylogenetic analysis of 28 streptococcal species. Journal of Clinical Microbiology. 42: 3686-95. PMID 15297518 DOI: 10.1128/Jcm.42.8.3686-3695.2004 |
0.567 |
|
| 2004 |
Huletsky A, Giroux R, Rossbach V, Gagnon M, Vaillancourt M, Bernier M, Gagnon F, Truchon K, Bastien M, Picard FJ, Van Belkum A, Ouellette M, Roy PH, Bergeron MG. New Real-Time PCR Assay for Rapid Detection of Methicillin-Resistant Staphylococcus aureus Directly from Specimens Containing a Mixture of Staphylococci Journal of Clinical Microbiology. 42: 1875-1884. PMID 15131143 DOI: 10.1128/Jcm.42.5.1875-1884.2004 |
0.369 |
|
| 2004 |
Boivin G, Côté S, Déry P, De Serres G, Bergeron MG. Multiplex real-time PCR assay for detection of influenza and human respiratory syncytial viruses. Journal of Clinical Microbiology. 42: 45-51. PMID 14715730 DOI: 10.1128/Jcm.42.1.45-51.2004 |
0.314 |
|
| 2003 |
Boissinot M, Bergeron MG. [Genomics and bioterrorism]. MéDecine Sciences : M/S. 19: 967-71. PMID 14613008 DOI: 10.1051/Medsci/20031910967 |
0.324 |
|
| 2003 |
Lapierre P, Huletsky A, Fortin V, Picard FJ, Roy PH, Ouellette M, Bergeron MG. Real-time PCR assay for detection of fluoroquinolone resistance associated with grlA mutations in Staphylococcus aureus. Journal of Clinical Microbiology. 41: 3246-51. PMID 12843071 DOI: 10.1128/Jcm.41.7.3246-3251.2003 |
0.364 |
|
| 2003 |
Bélanger SD, Boissinot M, Clairoux N, Picard FJ, Bergeron MG. Rapid detection of Clostridium difficile in feces by real-time PCR. Journal of Clinical Microbiology. 41: 730-4. PMID 12574274 DOI: 10.1128/Jcm.41.2.730-734.2003 |
0.339 |
|
| 2002 |
Piret J, Roy S, Gagnon M, Landry S, Désormeaux A, Omar RF, Bergeron MG. Comparative study of mechanisms of herpes simplex virus inactivation by sodium lauryl sulfate and n-lauroylsarcosine. Antimicrobial Agents and Chemotherapy. 46: 2933-42. PMID 12183250 DOI: 10.1128/Aac.46.9.2933-2942.2002 |
0.3 |
|
| 2002 |
Wang E, Simard M, Ouellet N, Bergeron Y, Beauchamp D, Bergeron MG. Pathogenesis of pneumococcal pneumonia in cyclophosphamide-induced leukopenia in mice. Infection and Immunity. 70: 4226-38. PMID 12117931 DOI: 10.1128/Iai.70.8.4226-4238.2002 |
0.648 |
|
| 2002 |
Bélanger SD, Boissinot M, Ménard C, Picard FJ, Bergeron MG. Rapid detection of Shiga toxin-producing bacteria in feces by multiplex PCR with molecular beacons on the smart cycler. Journal of Clinical Microbiology. 40: 1436-40. PMID 11923369 DOI: 10.1128/Jcm.40.4.1436-1440.2002 |
0.349 |
|
| 2002 |
Gagné JF, Désormeaux A, Perron S, Tremblay MJ, Bergeron MG. Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes. Biochimica Et Biophysica Acta. 1558: 198-210. PMID 11779569 DOI: 10.1016/S0005-2736(01)00432-1 |
0.311 |
|
| 2001 |
Bergeron MG, Ke D. New DNA-based PCR approaches for rapid real-time detection and prevention of group B streptococcal infections in newborns and pregnant women. Expert Reviews in Molecular Medicine. 3: 1-14. PMID 14585149 DOI: 10.1017/S1462399401003805 |
0.554 |
|
| 2001 |
Ke D, Bergeron MG. Molecular methods for rapid detection of group B streptococci. Expert Review of Molecular Diagnostics. 1: 175-81. PMID 11901812 DOI: 10.1586/14737159.1.2.175 |
0.578 |
|
| 2001 |
Wang E, Ouellet N, Simard M, Fillion I, Bergeron Y, Beauchamp D, Bergeron MG. Pulmonary and systemic host response to Streptococcus pneumoniae and Klebsiella pneumoniae bacteremia in normal and immunosuppressed mice. Infection and Immunity. 69: 5294-304. PMID 11500398 DOI: 10.1128/Iai.69.9.5294-5304.2001 |
0.66 |
|
| 2001 |
Dallaire F, Ouellet N, Bergeron Y, Turmel V, Gauthier MC, Simard M, Bergeron MG. Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia. The Journal of Infectious Diseases. 184: 292-300. PMID 11443554 DOI: 10.1086/322021 |
0.496 |
|
| 2001 |
Martineau F, Picard FJ, Ke D, Paradis S, Roy PH, Ouellette M, Bergeron MG. Development of a PCR assay for identification of staphylococci at genus and species levels. Journal of Clinical Microbiology. 39: 2541-7. PMID 11427566 DOI: 10.1128/Jcm.39.7.2541-2547.2001 |
0.708 |
|
| 2001 |
Fillion I, Ouellet N, Simard M, Bergeron Y, Sato S, Bergeron MG. Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/macrophage recruitment. Journal of Immunology (Baltimore, Md. : 1950). 166: 7353-61. PMID 11390486 DOI: 10.4049/Jimmunol.166.12.7353 |
0.462 |
|
| 2001 |
Roy S, Gourde P, Piret J, Désormeaux A, Lamontagne J, Haineault C, Omar RF, Bergeron MG. Thermoreversible gel formulations containing sodium lauryl sulfate or n-Lauroylsarcosine as potential topical microbicides against sexually transmitted diseases. Antimicrobial Agents and Chemotherapy. 45: 1671-81. PMID 11353610 DOI: 10.1128/Aac.45.6.1671-1681.2001 |
0.339 |
|
| 2001 |
Piret J, Lamontagne J, Désormeaux A, Bergeron MG. Efficacies of gel formulations containing foscarnet, alone or combined with sodium lauryl sulfate, against establishment and reactivation of latent herpes simplex virus type 1. Antimicrobial Agents and Chemotherapy. 45: 1030-6. PMID 11257012 DOI: 10.1128/Aac.45.4.1030-1036.2001 |
0.302 |
|
| 2001 |
Duong M, Simard M, Bergeron Y, Bergeron MG. Kinetic study of the inflammatory response in Streptococcus pneumoniae experimental pneumonia treated with the ketolide HMR 3004. Antimicrobial Agents and Chemotherapy. 45: 252-62. PMID 11120974 DOI: 10.1128/Aac.45.1.252-262.2001 |
0.504 |
|
| 2001 |
Dallaire F, Ouellet N, Simard M, Bergeron Y, Bergeron MG. Efficacy of recombinant human granulocyte colony-stimulating factor in a murine model of pneumococcal pneumonia: effects of lung inflammation and timing of treatment. The Journal of Infectious Diseases. 183: 70-7. PMID 11087202 DOI: 10.1086/317652 |
0.493 |
|
| 2000 |
Bergeron MG. Genetic tools for the simultaneous identification of bacterial species and their antibiotic resistance genes: Impact on clinical practice International Journal of Antimicrobial Agents. 16: 1-3. PMID 11185409 DOI: 10.1016/S0924-8579(00)00178-3 |
0.36 |
|
| 2000 |
Ke D, Boissinot M, Huletsky A, Picard FJ, Frenette J, Ouellette M, Roy PH, Bergeron MG. Evidence for horizontal gene transfer in evolution of elongation factor Tu in enterococci. Journal of Bacteriology. 182: 6913-20. PMID 11092850 DOI: 10.1128/Jb.182.24.6913-6920.2000 |
0.541 |
|
| 2000 |
Martineau F, Picard FJ, Grenier L, Roy PH, Ouellette M, Bergeron MG. Multiplex PCR assays for the detection of clinically relevant antibiotic resistance genes in staphylococci isolated from patients infected after cardiac surgery. The ESPRIT Trial. The Journal of Antimicrobial Chemotherapy. 46: 527-34. PMID 11020248 DOI: 10.1093/Jac/46.4.527 |
0.627 |
|
| 2000 |
Wang E, Simard M, Ouellet N, Bergeron Y, Beauchamp D, Bergeron MG. Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia. The Journal of Infectious Diseases. 182: 1255-9. PMID 10979929 DOI: 10.1086/315811 |
0.636 |
|
| 2000 |
Martineau F, Picard FJ, Ménard C, Roy PH, Ouellette M, Bergeron MG. Development of a rapid PCR assay specific for Staphylococcus saprophyticus and application to direct detection from urine samples. Journal of Clinical Microbiology. 38: 3280-4. PMID 10970371 DOI: 10.1128/Jcm.38.9.3280-3284.2000 |
0.64 |
|
| 2000 |
Piret J, Désormeaux A, Cormier H, Lamontagne J, Gourde P, Juhász J, Bergeron MG. Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice. Antimicrobial Agents and Chemotherapy. 44: 2263-70. PMID 10952566 DOI: 10.1128/Aac.44.9.2263-2270.2000 |
0.302 |
|
| 2000 |
Lansac N, Picard FJ, Ménard C, Boissinot M, Ouellette M, Roy PH, Bergeron MG. Novel genus-specific PCR-based assays for rapid identification of Neisseria species and Neisseria meningitidis. European Journal of Clinical Microbiology & Infectious Diseases. 19: 443-451. PMID 10947220 DOI: 10.1007/S100960000290 |
0.346 |
|
| 2000 |
Bergeron MG, Ke D, Ménard C, Picard FJ, Gagnon M, Bernier M, Ouellette M, Roy PH, Marcoux S, Fraser WD. Rapid detection of group B streptococci in pregnant women at delivery. The New England Journal of Medicine. 343: 175-9. PMID 10900276 DOI: 10.1056/NEJM200007203430303 |
0.554 |
|
| 2000 |
Wang E, Simard M, Bergeron Y, Beauchamp D, Bergeron MG. In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia. Antimicrobial Agents and Chemotherapy. 44: 1010-8. PMID 10722505 DOI: 10.1128/Aac.44.4.1010-1018.2000 |
0.667 |
|
| 2000 |
Ke D, Ménard C, Picard FJ, Boissinot M, Ouellette M, Roy PH, Bergeron MG. Development of conventional and real-time PCR assays for the rapid detection of group B streptococci. Clinical Chemistry. 46: 324-31. PMID 10702518 DOI: 10.1093/Clinchem/46.3.324 |
0.589 |
|
| 2000 |
Martineau F, Picard FJ, Lansac N, Ménard C, Roy PH, Ouellette M, Bergeron MG. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrobial Agents and Chemotherapy. 44: 231-8. PMID 10639342 DOI: 10.1128/Aac.44.2.231-238.2000 |
0.616 |
|
| 2000 |
Piret J, Lamontagne J, Bestman-Smith J, Roy S, Gourde P, Désormeaux A, Omar RF, Juhász J, Bergeron MG. In Vitro and In Vivo Evaluations of Sodium Lauryl Sulfate and Dextran Sulfate as Microbicides against Herpes Simplex and Human Immunodeficiency Viruses Journal of Clinical Microbiology. 38: 110-119. DOI: 10.1128/Jcm.38.1.110-119.2000 |
0.313 |
|
| 1999 |
Ke D, Picard FJ, Martineau F, Ménard C, Roy PH, Ouellette M, Bergeron MG. Development of a PCR assay for rapid detection of enterococci. Journal of Clinical Microbiology. 37: 3497-503. PMID 10523541 DOI: 10.1128/Jcm.37.11.3497-3503.1999 |
0.712 |
|
| 1999 |
Bergeron Y, Deslauriers AM, Ouellet N, Gauthier MC, Bergeron MG. Influence of cefodizime on pulmonary inflammatory response to heat-killed Klebsiella pneumoniae in mice. Antimicrobial Agents and Chemotherapy. 43: 2291-4. PMID 10471581 DOI: 10.1128/Aac.43.9.2291 |
0.476 |
|
| 1999 |
Bergeron Y, Ouellet N, Simard M, Olivier M, Bergeron MG. Immunomodulation of pneumococcal pulmonary infection with N(G)-monomethyl-L-arginine. Antimicrobial Agents and Chemotherapy. 43: 2283-90. PMID 10471580 DOI: 10.1128/Aac.43.9.2283 |
0.498 |
|
| 1999 |
LeBrun M, Grenier L, Gourde P, Bergeron MG, Labrecque G, Beauchamp D. Effectiveness and toxicity of gentamicin in an experimental model of pyelonephritis: effect of the time of administration. Antimicrobial Agents and Chemotherapy. 43: 1020-6. PMID 10223909 DOI: 10.1128/Aac.43.5.1020 |
0.334 |
|
| 1999 |
Gagné N, Cormier H, Omar RF, Désormeaux A, Gourde P, Tremblay MJ, Juhász J, Beauchamp D, Rioux JE, Bergeron MG. Protective effect of a thermoreversible gel against the toxicity of nonoxynol-9. Sexually Transmitted Diseases. 26: 177-83. PMID 10100776 DOI: 10.1097/00007435-199903000-00009 |
0.724 |
|
| 1999 |
Piret J, Gourde P, Cormier H, Désormeaux A, Beauchamp D, Tremblay MJ, Juhász J, Bergeron MG. Efficacy of Gel Formulations Containing free and Liposomal Foscarnet in a Murine Model of Cutaneous HSV-1 Infection Journal of Liposome Research. 9: 181-198. DOI: 10.3109/08982109909024785 |
0.316 |
|
| 1999 |
Picard FJ, Bergeron MG. Rapid diagnosis of bacterial infections using technologies based on nucleic acid detection Canadian Journal of Infectious Diseases. 10. DOI: 10.1155/1999/872430 |
0.362 |
|
| 1999 |
Bergeron Y, Bergeron MG. Why Does Pnemococcus Kill Canadian Journal of Infectious Diseases & Medical Microbiology. 10. DOI: 10.1155/1999/182623 |
0.501 |
|
| 1999 |
Bergeron Y, Bergeron MG. Why does pneumococcus kill? Canadian Journal of Infectious Diseases. 10. |
0.432 |
|
| 1998 |
Duong M, Simard M, Bergeron Y, Ouellet N, Côté-Richer M, Bergeron MG. Immunomodulating effects of HMR 3004 on pulmonary inflammation caused by heat-killed Streptococcus pneumoniae in mice. Antimicrobial Agents and Chemotherapy. 42: 3309-12. PMID 9835535 DOI: 10.1128/Aac.42.12.3309 |
0.473 |
|
| 1998 |
Duong M, Ouellet N, Simard M, Bergeron Y, Olivier M, Bergeron MG. Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. The Journal of Infectious Diseases. 178: 1472-82. PMID 9780270 DOI: 10.1086/314425 |
0.452 |
|
| 1998 |
Bergeron MG, Ouellette M. Preventing Antibiotic Resistance Using Rapid DNA-Based Diagnostic Tests Infection Control and Hospital Epidemiology. 19: 560-564. PMID 9758055 DOI: 10.1086/647873 |
0.314 |
|
| 1998 |
Bergeron Y, Ouellet N, Deslauriers AM, Simard M, Olivier M, Bergeron MG. Reduction by cefodizime of the pulmonary inflammatory response induced by heat-killed Streptococcus pneumoniae in mice. Antimicrobial Agents and Chemotherapy. 42: 2527-33. PMID 9756751 DOI: 10.1128/Aac.42.10.2527 |
0.488 |
|
| 1998 |
Bergeron MG, Ouellette M. Preventing antibiotic resistance through rapid genotypic identification of bacteria and of their antibiotic resistance genes in the clinical microbiology laboratory Journal of Clinical Microbiology. 36: 2169-2172. PMID 9665984 DOI: 10.1128/Jcm.36.8.2169-2172.1998 |
0.363 |
|
| 1998 |
Martineau F, Picard FJ, Roy PH, Ouellette M, Bergeron MG. Species-specific and ubiquitous-DNA-based assays for rapid identification of Staphylococcus aureus. Journal of Clinical Microbiology. 36: 618-23. PMID 9508283 DOI: 10.1128/Jcm.36.3.618-623.1998 |
0.649 |
|
| 1998 |
Bergeron Y, Ouellet N, Deslauriers AM, Simard M, Olivier M, Bergeron MG. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infection and Immunity. 66: 912-22. PMID 9488375 DOI: 10.1128/Iai.66.3.912-922.1998 |
0.481 |
|
| 1998 |
Muyombwe A, Olivier M, Harvie P, Bergeron MG, Ouellette M, Papadopoulou B. Protection against Leishmania major challenge infection in mice vaccinated with live recombinant parasites expressing a cytotoxic gee Journal of Infectious Diseases. 177: 188-195. PMID 9419187 DOI: 10.1086/513821 |
0.321 |
|
| 1998 |
Boivin G, Handfield J, Toma E, Murray G, Lalonde R, Tevere VJ, Sun R, Bergeron MG. Evaluation of the AMPLICOR Cytomegalovirus Test with Specimens from Human Immunodeficiency Virus-Infected Subjects Journal of Clinical Microbiology. 36: 2509-2513. DOI: 10.1128/Jcm.36.9.2509-2513.1998 |
0.305 |
|
| 1998 |
Leclerc F, Morin NJ, Bergeron MG, Beauchamp D. Relationship between intrarenal distribution and efficacy of fleroxacin in the treatment of Escherichia coli pyelonephritis in rats Journal of Infection and Chemotherapy. 4: 188-194. DOI: 10.1007/Bf02490165 |
0.354 |
|
| 1997 |
Beauchamp D, Laurent G, Grenier L, Gourde P, Zanen J, Heuson-Stiennon J, Bergeron MG. Attenuation of gentamicin-induced nephrotoxicity in rats by fleroxacin. Antimicrobial Agents and Chemotherapy. 41: 1237-1245. PMID 9174177 DOI: 10.1128/Aac.41.6.1237 |
0.323 |
|
| 1997 |
Omar RF, Harvie P, Gourde P, Désormeaux A, Tremblay M, Beauchamp D, Bergeron MG. Antiviral efficacy and toxicity of ribavirin and foscarnet each given alone or in combination in the murine AIDS model. Toxicology and Applied Pharmacology. 143: 140-51. PMID 9073602 DOI: 10.1006/Taap.1996.8080 |
0.315 |
|
| 1997 |
Turcotte A, Simard M, Morin NJ, Beauchamp D, Bergeron MG. Differential distributions in tissues and efficacies of aztreonam and ceftazidime and in vivo bacterial morphological changes following treatment Antimicrobial Agents and Chemotherapy. 41: 401-409. PMID 9021198 DOI: 10.1128/Aac.41.2.401 |
0.338 |
|
| 1996 |
Martineau F, Picard FJ, Roy PH, Ouellette M, Bergeron MG. Species-specific and ubiquitous DNA-based assays for rapid identification of Staphylococcus epidermidis. Journal of Clinical Microbiology. 34: 2888-93. PMID 8940417 |
0.604 |
|
| 1996 |
LeBrun M, Grenier L, Gourde P, Bergeron MG, Labrecque G, Beauchamp D. Nephrotoxicity of amphotericin B in rats: effects of the time of administration. Life Sciences. 58: 869-76. PMID 8786692 DOI: 10.1016/0024-3205(96)00029-X |
0.301 |
|
| 1995 |
Harvie P, Désormeaux A, Gagné N, Tremblay M, Poulin L, Beauchamp D, Bergeron MG. Lymphoid tissues targeting of liposome-encapsulated 2',3'-dideoxyinosine. Aids (London, England). 9: 701-7. PMID 7546414 DOI: 10.1097/00002030-199507000-00006 |
0.722 |
|
| 1995 |
DESLAURIERS AM, BERGERON Y, OLIVIER M, BEAUCHAMP D, GOURDE P, BERGERON MG. Low Rate of Phagocylosis and Overwheiming Inflammatory Reactions Cortribute to Mortality Rate in a Murine Model of Streptococcus Pneumoniae Pneumonia Journal of Immunotherapy. 17: 128. DOI: 10.1097/00002371-199502000-00060 |
0.344 |
|
| 1994 |
Beauchamp D, Gourde P, Simard M, Bergeron MG. Subcellular distribution of daptomycin given alone or with tobramycin in renal proximal tubular cells Antimicrobial Agents and Chemotherapy. 38: 189-194. PMID 8192441 DOI: 10.1128/Aac.38.2.189 |
0.322 |
|
| 1994 |
Lin L, Grenier L, Bergeron Y, Simard M, Bergeron MG, Labrecque G, Beauchamp D. Temporal changes of pharmacokinetics, nephrotoxicity, and subcellular distribution of tobramycin in rats. Antimicrobial Agents and Chemotherapy. 38: 54-60. PMID 8141580 DOI: 10.1128/Aac.38.1.54 |
0.464 |
|
| 1994 |
Thibault N, Grenier L, Simard M, Bergeron MG, Beauchamp D. Attenuation by daptomycin of gentamicin-induced experimental nephrotoxicity Antimicrobial Agents and Chemotherapy. 38: 1027-1035. PMID 8067733 DOI: 10.1128/Aac.38.5.1027 |
0.326 |
|
| 1994 |
Beauchamp D, Thériault G, Grenier L, Gourde P, Perron S, Bergeron Y, Fontaine L, Bergeron MG. Ceftriaxone protects against tobramycin nephrotoxicity. Antimicrobial Agents and Chemotherapy. 38: 750-6. PMID 8031041 DOI: 10.1128/Aac.38.4.750 |
0.482 |
|
| 1994 |
Couture M, Simard M, Gourde P, Lessard C, Gurnani K, Lin L, Carrier D, Bergeron MG, Beauchamp D. Daptomycin may attenuate experimental tobramycin nephrotoxicity by electrostatic complexation to tobramycin. Antimicrobial Agents and Chemotherapy. 38: 742-9. PMID 8031040 DOI: 10.1128/Aac.38.4.742 |
0.325 |
|
| 1994 |
Côté S, Sanschagrin F, Dargis M, Simard JL, Roy PH, MacDonald NE, Rabin HR, Bergeron MG, Malouin F. Molecular typing of Haemophilus influenzae using a DNA probe and multiplex PCR Molecular and Cellular Probes. 8: 23-37. PMID 8028605 DOI: 10.1006/Mcpr.1994.1004 |
0.325 |
|
| 1994 |
Bergeron MG, Bernier M. Bactericidal activity of cefpirome (HR 810) against 513 gram-negative bacteria isolated from blood of septicemic patients Infection. 22: 299-305. PMID 8002094 DOI: 10.1007/Bf01739925 |
0.321 |
|
| 1994 |
Tardif M, Beauchamp D, Bergeron Y, Lessard C, Gourde P, Bergeron MG. L-651,392, a potent leukotriene inhibitor, controls inflammatory process in Escherichia coli pyelonephritis. Antimicrobial Agents and Chemotherapy. 38: 1555-60. PMID 7979288 DOI: 10.1128/Aac.38.7.1555 |
0.492 |
|
| 1994 |
Morin NJ, Frau A, Nonclercq D, Toubeau G, Zanen J, Heuson-Stiennon J, Bergeron MG, Beauchamp D, Laurent G. Potentiation of Gentamicin Nephrotoxicity in the Rat by Infusion of Aprotinin Experimental and Molecular Pathology. 60: 197-213. PMID 7525340 DOI: 10.1006/Exmp.1994.1018 |
0.302 |
|
| 1993 |
Bergeron MG, Robert J, Beauchamp D. Pharmacodynamics of antibiotics in fibrin clots Journal of Antimicrobial Chemotherapy. 31: 113-136. PMID 8335514 DOI: 10.1093/Jac/31.Suppl_D.113 |
0.33 |
|
| 1993 |
Tardif M, Bergeron Y, Beauchamp D, Bergeron MG. Increased renal uptake of gentamicin in endotoxemic rats receiving concomitant thromboxane A2 antagonist therapy. Antimicrobial Agents and Chemotherapy. 37: 2727-32. PMID 8109943 DOI: 10.1128/Aac.37.12.2727 |
0.469 |
|
| 1992 |
Bergeron MG. What preclinical data are needed to justify once-daily therapy? Journal of Clinical Pharmacology. 32: 698-705. PMID 1487558 DOI: 10.1002/J.1552-4604.1992.Tb03872.X |
0.34 |
|
| 1992 |
Beauchamp D, Gourde P, Simard M, Bergeron MG. Subcellular localization of tobramycin and vancomycin given alone and in combination in proximal tubular cells, determined by immunogold labeling Antimicrobial Agents and Chemotherapy. 36: 2204-2210. PMID 1444301 DOI: 10.1128/Aac.36.10.2204 |
0.302 |
|
| 1992 |
Chamberland S, L'Ecuyer J, Lessard C, Bernier M, Provencher P, Bergeron MG. Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. The Canadian Study Group. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 15: 615-28. PMID 1420674 DOI: 10.1093/Clind/15.4.615 |
0.339 |
|
| 1992 |
Bergeron MG, Bernier M, L'Ecuyer J. In vitro activity of clarithromycin and its 14-hydroxy-metabolite against 203 strains of Haemophilus influenzae Infection. 20: 164-167. PMID 1386590 DOI: 10.1007/Bf01704612 |
0.304 |
|
| 1991 |
Joly V, Bergeron Y, Bergeron MG, Carbon C. Endotoxin-tobramycin additive toxicity on renal proximal tubular cells in culture. Antimicrobial Agents and Chemotherapy. 35: 351-7. PMID 1673835 |
0.408 |
|
| 1990 |
Jullien M, Thériault G, Bergeron MG, Beauchamp D. Effect of Enterococcus faecalis pyelonephritis on the intracortical accumulation kinetics of gentamicin in rats. The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses. 1: 117-20. PMID 22553452 DOI: 10.1155/1990/285781 |
0.309 |
|
| 1990 |
Kacew S, Bergeron MG. Pathogenic factors in aminoglycoside-induced nephrotoxicity Toxicology Letters. 51: 241-259. PMID 2187280 DOI: 10.1016/0378-4274(90)90067-V |
0.327 |
|
| 1990 |
Ngeleka M, Beauchamp D, Tardif D, Auclair P, Gourde P, Bergeron MG. Endotoxin increases the nephrotoxic potential of gentamicin and vancomycin plus gentamicin. The Journal of Infectious Diseases. 161: 721-7. PMID 2181033 DOI: 10.1093/Infdis/161.4.721 |
0.324 |
|
| 1990 |
Beauchamp D, Pellerin M, Gourde P, Pettigrew M, Bergeron MG. Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats Antimicrobial Agents and Chemotherapy. 34: 139-147. PMID 2158272 DOI: 10.1128/Aac.34.1.139 |
0.334 |
|
| 1989 |
Ngeleka M, Auclair P, Tardif D, Beauchamp D, Bergeron MG. Intrarenal distribution of vancomycin in endotoxemic rats. Antimicrobial Agents and Chemotherapy. 33: 1575-9. PMID 2817853 DOI: 10.1128/Aac.33.9.1575 |
0.319 |
|
| 1989 |
Bergeron MG, Bergeron Y, Tardif M, Marchand S, Beauchamp D. Influence of indomethacin on the intrarenal uptake of gentamicin in endotoxemic rats. Antimicrobial Agents and Chemotherapy. 33: 1342-5. PMID 2802560 DOI: 10.1128/Aac.33.8.1342 |
0.506 |
|
| 1989 |
Mandell LA, Bergeron MG, Ronald AR, Vega C, Harding G, Saginur R, Feld R, Duperval R, Landis SJ, Miedzinski LJ. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study. The Journal of Infectious Diseases. 160: 433-41. PMID 2668427 DOI: 10.1093/Infdis/160.3.433 |
0.328 |
|
| 1988 |
Auclair P, Lessard C, Bergeron MG. Renal pharmacokinetic changes of gentamicin during enterococcal pyelonephritis. Antimicrobial Agents and Chemotherapy. 32: 736-9. PMID 3134849 DOI: 10.1128/Aac.32.5.736 |
0.322 |
|
| 1988 |
Bergeron MG, Mendelson J, Harding GK, Mandell L, Fong IW, Rachlis A, Chan R, Biron S, Feld R, Segal NB. Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infections. Antimicrobial Agents and Chemotherapy. 32: 1231-1236. PMID 3056255 DOI: 10.1128/Aac.32.8.1231 |
0.326 |
|
| 1987 |
Bergeron MG, Bergeron Y, Beauchamp D. Influence of hydrocortisone succinate on intrarenal accumulation of gentamicin in endotoxemic rats. Antimicrobial Agents and Chemotherapy. 31: 1816-21. PMID 3435128 DOI: 10.1128/Aac.31.11.1816 |
0.492 |
|
| 1987 |
Bergeron MG, Marois Y, Kuehn C, Silverblatt FJ. Autoradiographic study of tobramycin uptake by proximal and distal tubules of normal and pyelonephritic rats Antimicrobial Agents and Chemotherapy. 31: 1359-1364. PMID 3314697 DOI: 10.1128/Aac.31.9.1359 |
0.33 |
|
| 1987 |
Bergeron MG, Ahronheim G, Richard JE, Riding K, Cron C, Bryer D, Macdonald N, Bouchard M, Young J, Dempsey EE. Comparative efficacies of erythromycin-sulfisoxazole and cefaclor in acute otitis media: a double blind randomized trial. The Pediatric Infectious Disease Journal. 6: 654-60. PMID 3302918 DOI: 10.1097/00006454-198707000-00007 |
0.318 |
|
| 1986 |
Bergeron MG, Bergeron Y, Marois Y. Autoradiography of tobramycin uptake by the proximal and distal tubules of normal and endotoxin-treated rats. Antimicrobial Agents and Chemotherapy. 29: 1005-9. PMID 3524435 DOI: 10.1128/Aac.29.6.1005 |
0.478 |
|
| 1986 |
Bergeron MG, Bergeron Y. Influence of endotoxin on the intrarenal distribution of gentamicin, netilmicin, tobramycin, amikacin, and cephalothin. Antimicrobial Agents and Chemotherapy. 29: 7-12. PMID 3524424 |
0.395 |
|
| 1986 |
Bergeron MG. Tissue penetration of antibiotics Clinical Biochemistry. 19: 90-100. PMID 3518994 DOI: 10.1016/S0009-9120(86)80054-6 |
0.334 |
|
| 1986 |
Bergeron MG, Simard P. Influence of three modes of administration on the penetration of latamoxef into interstitial fluid and fibrin clots and its in-vivo activity against haemophilus influenzae Journal of Antimicrobial Chemotherapy. 17: 775-784. PMID 3488309 DOI: 10.1093/Jac/17.6.775 |
0.313 |
|
| 1986 |
LeBel M, Bergeron MG, Vallée F, Fiset C, Chassé G, Bigonesse P, Rivard G. Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients. Antimicrobial Agents and Chemotherapy. 30: 260-266. PMID 3094438 DOI: 10.1128/Aac.30.2.260 |
0.306 |
|
| 1985 |
Beauchamp D, Poirier A, Bergeron MG. Increased nephrotoxicity of gentamicin in pyelonephritic rats Kidney International. 28: 106-113. PMID 3938828 DOI: 10.1038/Ki.1985.128 |
0.347 |
|
| 1985 |
LeBel M, Pellerin M, Bergeron MG. Serum bactericidal activity of ceftazidime increased by netilmicin Drug Intelligence and Clinical Pharmacy. 19: 932-936. PMID 3910388 DOI: 10.1177/106002808501901215 |
0.362 |
|
| 1982 |
Bergeron MG, Bastille A, Lessard C, Gagnon PM. Significance of intrarenal concentrations of gentamicin for the outcome of experimental pyelonephritis in rats Journal of Infectious Diseases. 146: 91-96. PMID 7045256 DOI: 10.1093/Infdis/146.1.91 |
0.305 |
|
| 1981 |
Bergeron MG, Beauchamp D, Poirier A, Bastille A. Continuous vs. Intermittent administration of antimicrobial agents: Tissue penetration and efficacy in vivo Reviews of Infectious Diseases. 3: 84-97. PMID 7013003 DOI: 10.1093/Clinids/3.1.84 |
0.353 |
|
| 1978 |
Bergeron MG, Nguyen BM, Gauvreau L. Influence of constant infusion versus bolus injections of antibiotics on in vivo synergy Infection. 6. DOI: 10.1007/Bf01646064 |
0.343 |
|
| 1976 |
Bergeron MG, Brusch JL, Barza M, Weinstein L. Bactericidal activity and pharmacology of flucloxacillin American Journal of the Medical Sciences. 271: 13-20. PMID 3969 DOI: 10.1097/00000441-197601000-00002 |
0.337 |
|
| 1974 |
Brusch JL, Bergeron MG, Barza M, Weinstein L. An in vitro and pharmacological comparison of amoxicillin and ampicillin American Journal of the Medical Sciences. 267: 41-48. PMID 4150176 DOI: 10.1097/00000441-197401000-00006 |
0.361 |
|
| Show low-probability matches. |